• 1214 引用
  • 12 h指数
1989 …2017
Pureに変更を加えた場合、すぐここに表示されます。

研究成果 1989 2017

フィルター
Article
2014

The pioneer of MOT in Japan

Tanaka, H., 2014, : : Development Engineering. 34, 1, p. 21-24 4 p.

研究成果: Article

2012
2010
2008

AUTM Technology Transfer Practice Manual, 3rd Edition, Volume Three, Part Two、 “The ownership of intellectual property rights which are raised through the collaboration between Universities and Industry in Japan”

Ku, K., Bres, O., Munson, F., Breit, G. G., Licata, J. M., White, A. E., Heller, P., Sparks, R. L., Roberts, J. S., Fasse, J. P., Kaiser, E., Murphy, S. L., Sibley, K. D., Burmania, J., Stewart, P. B., Jenkins, R. E., Kneller, R., Hideho, TANAKA., Chikako, SAOTOME. & Tanaka, H., 2008 1 1, : : Default journal.

研究成果: Article

2007
2001

COMPARATIVE EFFECTS OF THIAZOLIDINEDIONES ON PLASMA GLUCOSE AND TRIGLYCERIDES IN A MOUSE MODEL OF DIABETES

Shinnichi, ISHII., Hideho, TANAKA., Muneshige, SIRAHI. & Tanaka, H., 2001 9 12, : : Default journal.

研究成果: Article

1998

A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor y-activating properties.

Reginato, M. J., Krakow, S. T. B., Minami, C., Ishii, S., Tanaka, H. & Lazar, M. A., 1998 12 4, : : THE JOURNAL OF BIOLOGICAL CHEMISTRY. p. 32679-32684

研究成果: Article

174 引用 (Scopus)

A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor γ-activating properties

Reginato, M. J., Bailey, S. T., Krakow, S. L., Minami, C., Ishii, S., Tanaka, H. & Lazar, M. A., 1998 12 4, : : Journal of Biological Chemistry. 273, 49, p. 32679-32684 6 p.

研究成果: Article

Peroxisome Proliferator-Activated Receptors
Hypoglycemic Agents
Thiazolidinediones
rosiglitazone
Chemical activation
42 引用 (Scopus)

The development of overt diabetes in young Zucker Diabetic Fatty(ZDF) rats and the effects of chronic MCC-555 treatment

Pickavance, L., Widdowson, P. S., King-P, K-P., Ishii, S., Tanaka, H. & Williams, G., 1998 10 1, : : British Journal of Pharmacology. p. 767-770

研究成果: Article

42 引用 (Scopus)

The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment

Pickavance, L., Widdowson, P. S., King, P., Ishii, S., Tanaka, H. & Williams, G., 1998, : : British Journal of Pharmacology. 125, 4, p. 767-770 4 p.

研究成果: Article

35 引用 (Scopus)

The new antidiabetic drug MCC-555 acutely sensitizes insulin signaling in isolated cardiomyocytes

Liu, L. S., Tanaka, H., Ishii, S. & Eckel, J., 1998, : : Endocrinology. 139, 11, p. 4531-4539 9 p.

研究成果: Article

1996

MCC-555: A highly potent thiazolidinedione lacking hematological and cardiac side-effects

Shinichi, ISHII., Masahiko, WASAKI., Takayuki, OHE., Hiroaki, UENO., Hideho, TANAKA. & Tanaka, H., 1996 6 8, : : Default journal.

研究成果: Article

1995
256 引用 (Scopus)
Evans Blue
Dystrophin
Cell death
Muscle
Visualization
1994
37 引用 (Scopus)

A defective non-LTR retrotransposon is dispersed throughout the genome of the silkworm, Bombyx mori

Ogura, T., Okano, K., Tsuchida, K., Miyajima, N., Tanaka, H., Takada, N., Izumi, S., Tomino, S. & Maekawa, H., 1994 9, : : Chromosoma. 103, 5, p. 311-323 13 p.

研究成果: Article

1991
106 引用 (Scopus)
Cloning
Cartilage
Glycosylation
Fibroblast Growth Factor 2
Bioactivity

Molecular cloning of a novel cartilage-specific matrix, chondromodulin-I

Yuji, HIRAKI., Hideho, TANAKA., Hiroyuki, INOUE., Rujio, K. J. & Tanaka, H., 1991 8 1, : : Default journal.

研究成果: Article

1989
80 引用 (Scopus)
80 引用 (Scopus)

Adenylate cyclases in yeast; A comparison of the genes from Schizosaccharomyces pombe and Saccharomyces

Yamawaki-Kataoka, Y., Tamaoki, T., Choe, H-R., Tanaka, H. & Kotaoka, T., 1989 8 1, : : Proc. Natl. Acad. Sci. USA. p. 5693-5697

研究成果: Article